Shanghai Junshi Biosciences Co., Ltd. (HKG:1877)

HKG:1877 Statistics

Total Valuation

HKG:1877 has a market cap or net worth of HKD 42.62 billion. The enterprise value is 42.63 billion.

Market Cap	42.62B
Enterprise Value	42.63B

Important Dates

The next estimated earnings date is Tuesday, October 28, 2025.

Earnings Date	Oct 28, 2025
Ex-Dividend Date	n/a

Share Statistics

HKG:1877 has 1.03 billion shares outstanding. The number of shares has decreased by -0.62% in one year.

Current Share Class	260.30M
Shares Outstanding	1.03B
Shares Change (YoY)	-0.62%
Shares Change (QoQ)	+0.81%
Owned by Insiders (%)	18.22%
Owned by Institutions (%)	19.94%
Float	702.49M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	16.69
PB Ratio	6.08
P/TBV Ratio	6.62
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-37.09
EV / Sales	16.69
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-25.81

Financial Position

The company has a current ratio of 1.61, with a Debt / Equity ratio of 0.55.

Current Ratio	1.61
Quick Ratio	1.36
Debt / Equity	0.55
Debt / EBITDA	n/a
Debt / FCF	-2.32
Interest Coverage	-18.02

Financial Efficiency

Return on equity (ROE) is -17.82% and return on invested capital (ROIC) is -7.76%.

Return on Equity (ROE)	-17.82%
Return on Assets (ROA)	-6.52%
Return on Invested Capital (ROIC)	-7.76%
Return on Capital Employed (ROCE)	-13.59%
Revenue Per Employee	956,507
Profits Per Employee	-430,378
Employee Count	2,578
Asset Turnover	0.21
Inventory Turnover	1.00

Taxes

Income Tax	-589,164
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +124.30% in the last 52 weeks. The beta is 0.64, so HKG:1877's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	+124.30%
50-Day Moving Average	30.95
200-Day Moving Average	19.81
Relative Strength Index (RSI)	46.36
Average Volume (20 Days)	10,337,618

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:1877 had revenue of HKD 2.55 billion and -1.15 billion in losses. Loss per share was -1.17.

Revenue	2.55B
Gross Profit	1.95B
Operating Income	-1.30B
Pretax Income	-1.27B
Net Income	-1.15B
EBITDA	-1.02B
EBIT	-1.30B
Loss Per Share	-1.17

Balance Sheet

The company has 3.84 billion in cash and 3.83 billion in debt, giving a net cash position of 14.89 million or 0.01 per share.

Cash & Cash Equivalents	3.84B
Total Debt	3.83B
Net Cash	14.89M
Net Cash Per Share	0.01
Equity (Book Value)	7.00B
Book Value Per Share	6.81
Working Capital	1.99B

Cash Flow

In the last 12 months, operating cash flow was -983.88 million and capital expenditures -667.36 million, giving a free cash flow of -1.65 billion.

Operating Cash Flow	-983.88M
Capital Expenditures	-667.36M
Free Cash Flow	-1.65B
FCF Per Share	-1.61

Margins

Gross margin is 76.20%, with operating and profit margins of -50.76% and -44.99%.

Gross Margin	76.20%
Operating Margin	-50.76%
Pretax Margin	-49.71%
Profit Margin	-44.99%
EBITDA Margin	-39.99%
EBIT Margin	-50.76%
FCF Margin	n/a

Dividends & Yields

HKG:1877 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.62%
Shareholder Yield	n/a
Earnings Yield	-2.70%
FCF Yield	-3.87%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:1877 has an Altman Z-Score of 1.66 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.66
Piotroski F-Score	3